Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%

NCT03273556 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Nasolabial Folds Correction

Interventions

DEVICE: Aliaxin® EV Essential Volume (IBSA Farmaceutici Italia S.r.l.) with Lidocaine 0.3%
DEVICE: Aliaxin® EV Essential Volume (IBSA Farmaceutici Italia S.r.l.)

Sponsor

Derming SRL